Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 IndiviorPhathom PharmaceuticalsArcturus TherapeuticsRhythm PharmaceuticalsConstellation Pharmaceuticals
SymbolOTCMKTS:INVVYNASDAQ:PHATNASDAQ:ARCTNASDAQ:RYTMNASDAQ:CNST
Price Information
Current Price$9.33$37.00$39.52$20.74$23.29
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score0.81.81.61.81.2
Analysis Score0.03.33.13.43.4
Community Score1.92.52.62.62.4
Dividend Score0.00.00.00.00.0
Ownership Score0.02.51.72.50.0
Earnings & Valuation Score1.90.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price TargetN/A$53.00$70.67$50.67$45.29
% Upside from Price TargetN/A43.24% upside78.81% upside144.29% upside94.44% upside
Trade Information
Market Cap$1.37 billion$1.16 billion$1.04 billion$1.04 billion$1.11 billion
Beta0.31.323.011.572.8
Average Volume9,540101,3931,206,442482,318464,673
Sales & Book Value
Annual Revenue$785 millionN/A$20.79 millionN/AN/A
Price / Sales1.75N/A49.96N/AN/A
Cashflow$1.86 per shareN/AN/AN/AN/A
Price / Cash5.01N/AN/AN/AN/A
Book Value$1.43 per share$9.29 per share$1.70 per share$6.40 per share$8.23 per share
Price / Book6.52N/A23.25N/AN/A
Profitability
Net Income$134 million$-255,130,000.00$-25,990,000.00$-140,730,000.00$-85,550,000.00
EPS$1.15($13.98)($2.15)($3.86)($3.04)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio15.81N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-31.93%N/A-506.70%N/AN/A
Return on Equity (ROE)-4.15%-88.73%-52.32%-55.21%-28.88%
Return on Assets (ROA)-0.26%-69.04%-33.21%-50.73%-24.98%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.89%0.26%0.06%N/A0.05%
Current Ratio1.82%8.21%11.21%13.24%15.81%
Quick Ratio1.69%8.21%11.21%13.25%15.81%
Ownership Information
Institutional Ownership PercentageN/A73.80%74.33%88.43%N/A
Insider Ownership PercentageN/A39.80%12.60%9.49%10.60%
Miscellaneous
Employees7962511890154
Shares Outstanding146.92 million31.32 million26.28 million50.18 million47.86 million
Next Earnings Date5/13/2021 (Estimated)5/11/2021 (Estimated)5/6/2021 (Estimated)5/3/2021 (Estimated)5/5/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable
SourceHeadline
Zacks: Analysts Anticipate Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) to Announce -$0.80 Earnings Per ShareZacks: Analysts Anticipate Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) to Announce -$0.80 Earnings Per Share
americanbankingnews.com - April 10 at 8:08 AM
Constellation Pharmaceuticals (NASDAQ:CNST) Shares Gap Up to $22.81Constellation Pharmaceuticals (NASDAQ:CNST) Shares Gap Up to $22.81
americanbankingnews.com - April 9 at 10:44 AM
Is CNST Stock A Buy or Sell?Is CNST Stock A Buy or Sell?
finance.yahoo.com - April 8 at 11:59 AM
Royal Bank of Canada Reiterates Buy Rating for Constellation Pharmaceuticals (NASDAQ:CNST)Royal Bank of Canada Reiterates Buy Rating for Constellation Pharmaceuticals (NASDAQ:CNST)
americanbankingnews.com - April 7 at 12:48 PM
Constellation Pharmaceuticals (NASDAQ:CNST) Trading 5.4% Higher Constellation Pharmaceuticals (NASDAQ:CNST) Trading 5.4% Higher
americanbankingnews.com - April 5 at 1:08 PM
Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) Given Consensus Rating of "Buy" by BrokeragesConstellation Pharmaceuticals, Inc. (NASDAQ:CNST) Given Consensus Rating of "Buy" by Brokerages
americanbankingnews.com - April 1 at 6:50 AM
Constellation Pharmaceuticals (NASDAQ:CNST) Shares Up 2.9%Constellation Pharmaceuticals (NASDAQ:CNST) Shares Up 2.9%
americanbankingnews.com - March 25 at 11:19 AM
Notable Two Hundred Day Moving Average Cross - CNSTNotable Two Hundred Day Moving Average Cross - CNST
nasdaq.com - March 19 at 7:17 AM
Heres Why Were Not Too Worried About Constellation Pharmaceuticals (NASDAQ:CNST) Cash Burn SituationHere's Why We're Not Too Worried About Constellation Pharmaceuticals' (NASDAQ:CNST) Cash Burn Situation
finance.yahoo.com - February 26 at 7:17 AM
Constellation Pharmaceuticals (CNST) Q4 2020 Earnings Call TranscriptConstellation Pharmaceuticals (CNST) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 25 at 12:13 AM
CNST Crosses Below Key Moving Average LevelCNST Crosses Below Key Moving Average Level
nasdaq.com - February 24 at 7:12 PM
Why Constellations Stock is Trading Lower TodayWhy Constellation's Stock is Trading Lower Today
msn.com - February 24 at 12:51 PM
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial ResultsConstellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
finance.yahoo.com - February 24 at 7:37 AM
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial ResultsConstellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
finance.yahoo.com - February 24 at 7:37 AM
Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare ...Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare ...
apnews.com - February 19 at 7:57 PM
Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 ResultsConstellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
finance.yahoo.com - February 18 at 1:16 PM
Pharma Stock Ideas: Why BMO Is Recommending Regeneron, ConstellationPharma Stock Ideas: Why BMO Is Recommending Regeneron, Constellation
markets.businessinsider.com - January 25 at 1:53 PM
CNST Feb 2021 30.000 callCNST Feb 2021 30.000 call
uk.finance.yahoo.com - January 19 at 5:02 PM
CNST210115P00025000 (CNST210115P00025000) interactive stock chart – Yahoo FinanceCNST210115P00025000 (CNST210115P00025000) interactive stock chart – Yahoo Finance
au.finance.yahoo.com - December 23 at 10:50 PM
CNST210319C00035000 (CNST210319C00035000) interactive stock chart – Yahoo FinanceCNST210319C00035000 (CNST210319C00035000) interactive stock chart – Yahoo Finance
in.finance.yahoo.com - December 21 at 10:36 PM
CNST Jan 2021 25.000 putCNST Jan 2021 25.000 put
uk.finance.yahoo.com - December 21 at 10:36 PM
CNST Jan 2021 22.500 putCNST Jan 2021 22.500 put
uk.finance.yahoo.com - December 21 at 5:36 PM
CNST Jan 2021 15.000 putCNST Jan 2021 15.000 put
uk.finance.yahoo.com - December 21 at 7:34 AM
CNST Jan 2021 35.000 callCNST Jan 2021 35.000 call
in.finance.yahoo.com - December 21 at 7:34 AM
CNST Jan 2021 40.000 putCNST Jan 2021 40.000 put
uk.finance.yahoo.com - December 21 at 7:34 AM
DateCompanyBrokerageAction
7/27/2020IndiviorCitigroupUpgrade
7/27/2020IndiviorJefferies Financial GroupUpgrade
7/27/2020IndiviorStifel NicolausUpgrade
2/17/2021Phathom PharmaceuticalsBMO Capital MarketsInitiated Coverage
2/2/2021Phathom PharmaceuticalsGuggenheimInitiated Coverage
1/28/2021Phathom PharmaceuticalsJonestradingInitiated Coverage
12/15/2020Phathom PharmaceuticalsNeedham & Company LLCBoost Price Target
6/26/2020Phathom PharmaceuticalsThe Goldman Sachs GroupDowngrade
11/27/2019Phathom PharmaceuticalsEvercore ISIInitiated Coverage
3/8/2021Arcturus TherapeuticsB. RileyLower Price Target
3/2/2021Arcturus TherapeuticsRoth CapitalLower Price Target
1/7/2021Arcturus TherapeuticsWells Fargo & CompanyInitiated Coverage
12/29/2020Arcturus TherapeuticsHC WainwrightDowngrade
12/29/2020Arcturus TherapeuticsRobert W. BairdDowngrade
12/29/2020Arcturus TherapeuticsBarclaysDowngrade
12/29/2020Arcturus TherapeuticsRaymond JamesDowngrade
12/14/2020Arcturus TherapeuticsCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
12/14/2020Arcturus TherapeuticsSmith Barney CitigroupBoost Price Target
8/25/2020Arcturus TherapeuticsPiper SandlerInitiated Coverage
8/11/2020Arcturus TherapeuticsBrookline Capital ManagementReiterated Rating
3/9/2021Rhythm PharmaceuticalsMorgan StanleyBoost Price Target
1/27/2021Rhythm PharmaceuticalsCanaccord GenuityBoost Price Target
1/27/2021Rhythm PharmaceuticalsLADENBURG THALM/SH SHBoost Price Target
11/30/2020Rhythm PharmaceuticalsBank of AmericaDowngrade
9/25/2019Rhythm PharmaceuticalsCowenReiterated Rating
4/7/2021Constellation PharmaceuticalsRoyal Bank of CanadaReiterated Rating
9/24/2020Constellation PharmaceuticalsOppenheimerReiterated Rating
6/24/2020Constellation PharmaceuticalsJMP SecuritiesInitiated Coverage
2/13/2020Constellation PharmaceuticalsSunTrust BanksInitiated Coverage
(Data available from 4/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.